Adam Mor

3.5k total citations
65 papers, 2.7k citations indexed

About

Adam Mor is a scholar working on Immunology, Oncology and Immunology and Allergy. According to data from OpenAlex, Adam Mor has authored 65 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Immunology, 19 papers in Oncology and 16 papers in Immunology and Allergy. Recurrent topics in Adam Mor's work include T-cell and B-cell Immunology (16 papers), Cell Adhesion Molecules Research (14 papers) and Immune Cell Function and Interaction (13 papers). Adam Mor is often cited by papers focused on T-cell and B-cell Immunology (16 papers), Cell Adhesion Molecules Research (14 papers) and Immune Cell Function and Interaction (13 papers). Adam Mor collaborates with scholars based in United States, Israel and India. Adam Mor's co-authors include Mark R. Philips, Michael H. Pillinger, Steven B. Abramson, Michael L. Dustin, G. Keren, David Planer, Jacob George, Galia Luboshits, Marianne Strazza and Ian M. Ahearn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Adam Mor

65 papers receiving 2.7k citations

Peers

Countries citing papers authored by Adam Mor

Since Specialization

Citations

This map shows the geographic impact of Adam Mor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Mor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Mor more than expected).

Fields of papers citing papers by Adam Mor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Mor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Mor. The network helps show where Adam Mor may publish in the future.

Co-authorship network of co-authors of Adam Mor

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Mor. A scholar is included among the top collaborators of Adam Mor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Mor. Adam Mor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Transmembrane domain–driven PD-1 dimers mediate T cell inhibition 2024 ·Science Immunology ·(unknown), Jia Liu, Audun Kvalvaag, (unknown), Anna S. Tocheva, Charles Ng, (unknown), Ian M. Ahearn, (unknown), Christina C. Luo, Alexander Leithner, (unknown), Yong Zhou, Antonio García‐España, Adam Mor, Dan R. Littman, Michael L. Dustin, Jun Wang, Xiang‐Peng Kong	17
2	Inhibition of IL-25/IL-17RA improves immune-related adverse events of checkpoint inhibitors and reveals antitumor activity 2024 ·Journal for ImmunoTherapy of Cancer ·(unknown), Shoiab Bukhari, (unknown), Kieran Adam, Shalom Lerrer, Brian S. Henick, Robert Winchester, Adam Mor	4
3	Mesencephalic astrocyte-derived neurotrophic factor is secreted from interferon-γ–activated tumor cells through ER calcium depletion 2021 ·PLoS ONE ·Michael Peled, (unknown), (unknown), (unknown), (unknown), Jair Bar, Iris Kamer, Efrat Ofek, Adam Mor, Amir Onn	5
4	A novel mouse model for checkpoint inhibitor-induced adverse events 2021 ·PLoS ONE ·Kieran Adam, Alina C. Iuga, Anna S. Tocheva, Adam Mor	45
5	Isolation and Characterization of T Lymphocyte-Exosomes Using Mass Spectrometry 2020 ·Methods in molecular biology ·Inbar Azoulay‐Alfaguter, Adam Mor	4
6	Immune checkpoint inhibitors and the shared epitope theory: from hypothesis to practice 2019 ·Translational Cancer Research ·Shalom Lerrer, Adam Mor	4
7	MicroRNA-4443 regulates mast cell activation by T cell–derived microvesicles 2017 ·Journal of Allergy and Clinical Immunology ·Irit Shefler, Pazit Salamon, Francesca Levi‐Schaffer, Adam Mor, Alon Y. Hershko, Yoseph A. Mekori	35
8	Rap1 and its effector RIAM are required for lymphocyte trafficking 2015 ·Blood ·Wenjuan Su, Joseph Wynne, Elaine M. Pinheiro, Marianne Strazza, Adam Mor, Emilie Montenont, Jeffrey S. Berger, David S. Paul, Wolfgang Bergmeier, Frank B. Gertler, Mark R. Philips	59
9	Chaperone-mediated specificity in Ras and Rap signaling 2014 ·Critical Reviews in Biochemistry and Molecular Biology ·Inbar Azoulay‐Alfaguter, Marianne Strazza, Adam Mor	9
10	Ras Chaperones 2013 ·The Enzymes ·Yoel Kloog, Galit Elad‐Sfadia, Roni Haklai, Adam Mor	8
11	Immunomodulatory Properties of Farnesoids: The New Steroids? 2013 ·Current Medicinal Chemistry ·Adam Mor, (unknown), Joab Chapman, Yoel Kloog	9
12	Drugs Causing Muscle Disease 2011 ·Rheumatic Disease Clinics of North America ·Adam Mor, Robert L. Wortmann, Hal J. Mitnick, Michael H. Pillinger	15
13	T Cell-Induced Mast Cell Activation: A Role for Microparticles Released from Activated T Cells 2010 ·The Journal of Immunology ·Irit Shefler, Pazit Salamon, Tamar Reshef, Adam Mor, Yoseph A. Mekori	79
14	Inhibitory Effect of Farnesylthiosalicylic Acid on Mediators Release by Mast Cells: Preferential Inhibition of Prostaglandin D2 and Tumor Necrosis Factor-α Release 2010 ·Inflammation ·Adam Mor, Ofer Ben‐Moshe, Yoseph A. Mekori, Yoel Kloog	6
15	Autoimmunity and mast cell-related diseases 2008 ·Expert Review of Clinical Immunology ·Eyal Reinstein, Yoseph A. Mekori, Adam Mor	1
16	The role of Ras signaling in lupus T lymphocytes: Biology and pathogenesis 2007 ·Clinical Immunology ·Adam Mor, Mark R. Philips, Michael H. Pillinger	32
17	The lymphocyte function-associated antigen-1 receptor costimulates plasma membrane Ras via phospholipase D2 2007 ·Nature Cell Biology ·Adam Mor, Gabriele Campi, Guangwei Du, Zheng Yang, David A. Foster, Michael L. Dustin, Mark R. Philips	114
18	PKC Regulates a Farnesyl-Electrostatic Switch on K-Ras that Promotes its Association with Bcl-Xl on Mitochondria and Induces Apoptosis 2006 ·Molecular Cell ·Trever G. Bivona, Steven Quatela, Brian O. Bodemann, Ian M. Ahearn, Michael J. Soskis, Adam Mor, John T. Miura, Heidi H. Wiener, (unknown), Shahryar Saba, Duke Yim, Adam J. Fein, Ignacío Pérez de Castro, Chi Li, Craig B. Thompson, Adrienne D. Cox, Mark R. Philips	380
19	Altered status of CD4+CD25+ regulatory T cells in patients with acute coronary syndromes 2006 ·European Heart Journal ·Adam Mor, Galia Luboshits, David Planer, G. Keren, Jacob George	259
20	Evaluation of Disease Severity in Familial Mediterranean Fever 2005 ·Seminars in Arthritis and Rheumatism ·Adam Mor, Yael Shinar, Nurit Zaks, Pnina Langevitz, Angela Chetrit, Shmuel Shtrasburg, (unknown), Avi Livneh	105

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact